Bear of the Day: Valeant Pharma
July 17, 2016 at 08:13 AM EDT
Valeant posted a net loss of $373.7 million in Q1 compared to a net gain of $97.7 million in Q1 15.Also, adjusted net income was only $442.6 million compared to $704.2 in the year ago quarter.
